Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : RKP00156
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Study Phase : Phase I
Sponsor : Aska Pharmaceutical
Deal Size : Undisclosed
Deal Type : Agreement
Details : Under the agreement, ASKA will obtain a right to exercise an option to jointly develop with KinoPharma and to exclusively sell the drug in Japan.
Product Name : RKP00156
Product Type : Other Small Molecule
Upfront Cash : Undisclosed
January 14, 2020
Lead Product(s) : RKP00156
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Phase I
Sponsor : Aska Pharmaceutical
Deal Size : Undisclosed
Deal Type : Agreement